Joshua Scharff

982 total citations
19 papers, 762 citations indexed

About

Joshua Scharff is a scholar working on Immunology, Biotechnology and Genetics. According to data from OpenAlex, Joshua Scharff has authored 19 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 8 papers in Biotechnology and 4 papers in Genetics. Recurrent topics in Joshua Scharff's work include Toxin Mechanisms and Immunotoxins (11 papers), Transgenic Plants and Applications (7 papers) and Microbial Inactivation Methods (5 papers). Joshua Scharff is often cited by papers focused on Toxin Mechanisms and Immunotoxins (11 papers), Transgenic Plants and Applications (7 papers) and Microbial Inactivation Methods (5 papers). Joshua Scharff collaborates with scholars based in United States, United Kingdom and Netherlands. Joshua Scharff's co-authors include David M. Neville, Michael J. Dobersen, Fredda Ginsberg‐Fellner, Abner Louis Notkins, Huaizhong Hu, Kasturi Srinivasachar, Stuart J. Knechtle, John H. Fechner, Michael J. Hanaway and Yuan Zhai and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Joshua Scharff

19 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joshua Scharff United States 12 352 300 244 166 155 19 762
James A. Dromey Australia 12 328 0.9× 229 0.8× 256 1.0× 123 0.7× 4 0.0× 14 887
Ernest W. Larkin United States 12 50 0.1× 238 0.8× 53 0.2× 184 1.1× 25 0.2× 18 670
R. Behboo United States 8 147 0.4× 201 0.7× 185 0.8× 80 0.5× 8 0.1× 26 424
Elisa K. Boden United States 8 932 2.6× 82 0.3× 265 1.1× 15 0.1× 34 0.2× 20 1.1k
G. P. Sandilands United Kingdom 13 383 1.1× 43 0.1× 122 0.5× 14 0.1× 10 0.1× 40 809
Diana M. Cowen United Kingdom 7 150 0.4× 90 0.3× 35 0.1× 13 0.1× 18 0.1× 8 420
L Legrand France 16 362 1.0× 52 0.2× 78 0.3× 12 0.1× 40 0.3× 37 585
Paul S. Seifert United States 16 428 1.2× 217 0.7× 18 0.1× 18 0.1× 11 0.1× 29 850
John Napoli Australia 10 180 0.5× 129 0.4× 41 0.2× 20 0.1× 24 0.2× 14 795
Ji-Lao Fan United States 12 214 0.6× 44 0.1× 60 0.2× 109 0.7× 6 0.0× 16 520

Countries citing papers authored by Joshua Scharff

Since Specialization
Citations

This map shows the geographic impact of Joshua Scharff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua Scharff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua Scharff more than expected).

Fields of papers citing papers by Joshua Scharff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua Scharff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua Scharff. The network helps show where Joshua Scharff may publish in the future.

Co-authorship network of co-authors of Joshua Scharff

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua Scharff. A scholar is included among the top collaborators of Joshua Scharff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua Scharff. Joshua Scharff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Fechner, John H., Yinchen Dong, Xuening Hong, et al.. (2001). GRAFT SURVIVAL IN A RHESUS RENAL TRANSPLANT MODEL AFTER IMMUNOTOXIN-MEDIATED T-CELL DEPLETION IS ENHANCED BY MYCOPHENOLATE AND STEROIDS1,2. Transplantation. 72(4). 581–587. 8 indexed citations
2.
Hu, Huaizhong, Scott Stavrou, Carlo Tornatore, et al.. (1997). Depletion of T Lymphocytes with Immunotoxin Retards the Progress of Experimental Allergic Encephalomyelitis in Rhesus Monkeys. Cellular Immunology. 177(1). 26–34. 19 indexed citations
3.
Knechtle, Stuart J., Daniel Vargo, John H. Fechner, et al.. (1997). FN18-CRM9 IMMUNOTOXIN PROMOTES TOLERANCE IN PRIMATE RENAL ALLOGRAFTS1. Transplantation. 63(1). 1–6. 168 indexed citations
4.
Ma, Shenglin, et al.. (1997). Genetic Construction and Characterization of an Anti-Monkey CD3 Single-Chain Immunotoxin with a Truncated Diphtheria Toxin. Bioconjugate Chemistry. 8(5). 695–701. 13 indexed citations
5.
Monte, Lucia De, et al.. (1996). Bispecific anti-CD3/CD4-CRM9: A novel bifunctional immunotoxin targeting CD3+CD4+T cells. 2. 76–84. 3 indexed citations
6.
Neville, David M., et al.. (1996). A New Reagent for the Induction of T-Cell Depletion, Anti-CD3-CRM9. Journal of Immunotherapy. 19(2). 85–92. 67 indexed citations
7.
Scharff, Joshua, et al.. (1995). Selective killing of T cells by immunotoxins directed at distinct Vβ epitopes of the T cell receptor. European Journal of Immunology. 25(7). 2077–2082. 3 indexed citations
8.
Hu, Huaizhong, et al.. (1995). An Anti-CD3 Single-chain Immunotoxin with a Truncated Diphtheria Toxin Avoids Inhibition by Pre-existing Antibodies in Human Blood. Journal of Biological Chemistry. 270(47). 28037–28041. 37 indexed citations
9.
Neville, David M., Joshua Scharff, & Kasturi Srinivasachar. (1993). Anti-T cell immunotoxins: a look at post-endocytotic receptor-mediated routing. Journal of Controlled Release. 24(1-3). 133–144. 7 indexed citations
10.
Akeson, Mark, Joshua Scharff, Celia Sharp, & David M. Neville. (1992). Evidence that plasma membrane electrical potential is required for vesicular stomatitis virus infection of MDCK cells: A study using fluorescence measurements through polycarbonate supports. The Journal of Membrane Biology. 125(1). 81–91. 8 indexed citations
11.
Neville, David M., Joshua Scharff, & Kasturi Srinivasachar. (1992). In vivo T-cell ablation by a holo-immunotoxin directed at human CD3.. Proceedings of the National Academy of Sciences. 89(7). 2585–2589. 50 indexed citations
12.
Dorsch, Walter, Joshua Scharff, Thomas Bayer, & H. Wagner. (1989). Antiasthmatic effects of onions. Prevention of platelet-activating factor induced bronchial hyperreactivity to histamine in guinea pigs by diphenylthiosulfinate.. PubMed. 88(1-2). 228–30. 10 indexed citations
13.
Neville, David M., et al.. (1989). Enhancement of Immunotoxin Efficacy by Acid-cleavable Cross-linking Agents Utilizing Diphtheria Toxin and Toxin Mutants. Journal of Biological Chemistry. 264(25). 14653–14661. 30 indexed citations
14.
Hudson, Thomas H., et al.. (1988). Energy requirements for diphtheria toxin translocation are coupled to the maintenance of a plasma membrane potential and a proton gradient.. Journal of Biological Chemistry. 263(10). 4773–4781. 31 indexed citations
15.
Scharff, Joshua, et al.. (1986). Gastrointestinal Carcinoma-Associated Antigen Defined by a Murine Monoclonal Antibody. JNCI Journal of the National Cancer Institute. 77(3). 599–604. 6 indexed citations
16.
Garzelli, Carlo, Floyd Taub, Joshua Scharff, et al.. (1984). Epstein-Barr virus-transformed lymphocytes produce monoclonal autoantibodies that react with antigens in multiple organs. Journal of Virology. 52(2). 722–725. 85 indexed citations
17.
Dobersen, Michael J. & Joshua Scharff. (1982). Preferential Lysis of Pancreatic B-Cells by Islet Cell Surface Antibodies. Diabetes. 31(5). 459–462. 40 indexed citations
18.
Dobersen, Michael J., Joshua Scharff, & Abner Louis Notkins. (1980). Microculture System for Studying Monolayers of Functionalβ-Cells. Endocrinology. 106(4). 1070–1073. 12 indexed citations
19.
Dobersen, Michael J., Joshua Scharff, Fredda Ginsberg‐Fellner, & Abner Louis Notkins. (1980). Cytotoxic Autoantibodies to Beta Cells in the Serum of Patients with Insulin-Dependent Diabetes Mellitus. New England Journal of Medicine. 303(26). 1493–1498. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James A. Dromey Breakdown of academic impact, for papers by Ernest W. Larkin Breakdown of academic impact, for papers by R. Behboo Breakdown of academic impact, for papers by Elisa K. Boden Breakdown of academic impact, for papers by G. P. Sandilands Breakdown of academic impact, for papers by Diana M. Cowen Breakdown of academic impact, for papers by L Legrand Breakdown of academic impact, for papers by Paul S. Seifert Breakdown of academic impact, for papers by John Napoli Breakdown of academic impact, for papers by Ji-Lao Fan
Rankless by CCL
2026